Latest PolarisQB News & Updates

PolarisQB and PTG announce exclusive representation in China and ASEAN

PTG will identify and develop commercial opportunities for PolarisQB's quantum-powered drug discovery platform QuADD across the region.

PolarisQB demonstrates advances in drug safety prediction using quantum-inspired AI

The study shows significant improvements in ADMET benchmarks, enabling earlier elimination of toxic compounds. Results highlight gains in CYP3A4 and hERG predictions.

PolarisQB wins 2026 Cleveland Clinic Quantum Innovation Catalyzer Program

They collaborate with Cleveland Clinic researchers using IBM Quantum System One to advance quantum machine learning for ADME-Tox prediction in drug discovery.

PolarisQB announces new published manuscript

The paper by its Director of Chemistry and CEO compares QuADD platform favorably to BInD in small-molecule generation for drug design.

PolarisQB Unveils QuADD Quantum-AI Drug Discovery Platform

DURHAM, N.C., Aug. 13, 2025 — Polaris Quantum Biotech (PolarisQB), a leader in quantum-powered life science solutions, has announced the official launch of...

PolarisQB Receives DARPA EEI Award to Advance Quantum Computing for Drug Design

DURHAM, NC, UNITED STATES, September 30, 2025 /EINPresswire.com/ -- The Defense Advanced Research Projects Agency (DARPA) awarded PolarisQB an Embedded ...

5 Q’s for Bill Shipman, Co-founder and CTO of Polaris Quantum Biotech

Bill Shipman, co-founder and chief technology officer of Polaris Quantum Biotech, a North Carolina-based company that uses quantum computing to help discover...

PolarisQB Announces Integration of Virtual Libraries from Liverpool ChiroChem into Quantum-Aided Drug Design - FOX 2